Cite
HARVARD Citation
van der Heijde, D. et al. (2009). Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Annals of the rheumatic diseases. 68 (6), pp. 922-929. [Online].